TIS and IDEMIA Join Forces to Provide Biometric Digital Identity Solutions for Financial Institutions, Using IDEMIA’s Digital Identity Platform for Research and Development
Going forward, the two companies aim to conduct verification testing in Japan throughout 2018 targeted at financial institutions such as banks and credit card companies, amongst others, through joint research and development of highly secure and reliable biometric digital identity solutions based on IDEMIA’s digital identity and payment platform.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180531005666/en/
Biometric digital identity solutions for financial institutions are solutions that support the utilization of digital identity technologies, including biometric authentication, identity verification, and digital signatures. The incorporation of advanced digital identity technologies will enable the development of secure and convenient services for end users.
TIS has developed the brand-name of “PAYCIERGE”, based on its rich experience with development of critical systems for credit card companies and cutting-edge technologies. It has developed a broad range of services, from business systems that perform debit and prepaid card processing to mobile solutions in close proximity to the consumer for enhancing user convenience.
IDEMIA is the global leader in the fields of biometrics (fingerprint, facial and iris authentication), digital identity, and payment solutions. It has dozens of years of expertise worldwide, across the entire value chain in the field of Augmented Identity and provides numerous public and private markets with the most exhaustive digital trust suite (identity-verification technologies, risk-based authentication, Omni-channel online contracts, digital payments, etc.).
TIS and IDEMIA are now aiming to blend the two companies’ technologies to offer highly reliable and convenient mobile-based biometric digital identity solutions for financial institutions such as banks and credit card companies.
The following outline some of its uses:
- Enabling the opening of a bank account within just a few minutes from a remote location while maintaining regulatory (KYC*, AML*, etc.) compliance.
- Using facial authentication for secure access and performing highly-sensitive transactions (funds transfers and online payments).
- Enabling enrolment anytime, anywhere, and on any device in any type of financial product (loans, savings, life insurance, etc.) in a legally-compliant form.
TIS has been developing the new concept “PAYCIERGE 2.0” since 2016, which is adapted to the needs of the ever-evolving payments business market and offering the new solutions to this market. The linkage of the biometric authentication technology and services of IDEMIA with the financial industry experience and technologies acquired by TIS will increase the value of services in the consumer domain and create a variety of payment services with high levels of security and usability.
Pierre Barrial, Executive Vice-President of IDEMIA’s Financial Institutions Business Unit, made the following comments with respect to this joint research: “I am proud of our partnership with TIS. By combining IDEMIA’s best-in-class knowledge in ID integration and TIS’s outstanding IS integration, we can create superior value-added services for Japanese financial institutions, acquire new customers, speed up market entry, and reduce integration costs.”
Kiyotaka Nakamura, TIS Managing Executive Officer and Division Manager of the Payment Services Division of the Service Strategy Sector, made the following comments: “I am very happy that we were able to announce the research and development efforts with IDEMIA, the global leader in Augmented Identity. TIS has been developing “PAYCIERGE” solutions, but the importance of security and usability has become clear with recent progress in FinTech. We will see business innovation and market creation in the payments domain utilizing the experience and technologies acquired by TIS and the security technologies and high-usability solutions of IDEMIA.”
*KYC: Know Your Customer
*AML: Anti-Money Laundering
TIS retail payments solution, “PAYCIERGE”, is the comprehensive brand for retail payment solutions that provide very convenient, secure mechanisms to all customers who need to make retail payments. “PAYCIERGE 2.0” is a new concept adapted to the needs of the ever-evolving payments business market. It helps broadly with business success by incorporating reliable systems and secure operations that leverage the advanced technologies, which have an overwhelming market share in the credit card industry, and rich know-how of TIS under the theme of “connections”, which includes strengthening “connections” by making alliances, strengthening “connections” with an open API platform, and developing overseas markets.
For more details, please refer to the following URL:
TIS of TIS INTEC Group offers a variety of service-oriented IT solutions, such as data centers and cloud IT solutions in addition to SI and commissioned development. At the same time, it has a global support system centralized in the China and ASEAN region, which supports more than 3000 business partners in various industries such as finance, manufacturing, distribution/service, public sector, and communications to contribute to the growth of our customers’ businesses.
For more details, please refer to the following URL:
OT-Morpho is now IDEMIA, the global leader in Augmented Identity, with
the ambition to empower citizens and consumers alike to interact, pay,
connect, travel, and vote in ways that are now possible in a connected
Securing our identities has become mission critical in the world we live in today. By standing for Augmented Identity, we reinvent the way we think, produce, use and protect this asset, whether for individuals or for objects. We ensure privacy and trust as well as guarantee secure, authenticated and verifiable transactions for international clients from Financial, Telecom, Identity, Public Security and IoT sectors.
OT (Oberthur Technologies) and Safran Identity & Security (Morpho) have joined forces to form IDEMIA. With close to $3 billion in revenue and 14,000 employees around the world, IDEMIA serves clients in 180 countries.
HAVAS PARIS PR Agency
Corporate Planning SBU
Corporate Communication Department
Details for inquiries:
Service Strategy Secto
Payment Services Division
PAYCIERGE general contact
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
American Express Wins Major Antitrust Lawsuit25.6.2018 18:05 | Pressemelding
American Express (NYSE:AXP) issued the following statement today from Chairman and CEO Stephen J. Squeri regarding the U.S. Supreme Court’s decision in the Department of Justice’s antitrust lawsuit: “The Court’s decision is a major victory for consumers and for American Express. “This was a long battle, but well worth the fight because important issues were at stake: consumer choice, fair market competition, and the ability to deliver innovative products and services to our customers, both consumers and merchants. “As the Supreme Court stated today, ‘…Amex’s business model has stimulated competitive innovations in the credit-card market, increasing the volume of transactions and improving the quality of the services.’ “Since this case started eight years ago, we have significantly expanded the network of merchants who willingly accept American Express, and have seen merchant satisfaction steadily increase. We have also broadened the range of benefits, services and experiences that buil
Synteract Announces Collaboration with International Children’s Advisory Network iCAN Research25.6.2018 17:03 | Pressemelding
Synteract, an innovative contract research organization (CRO) providing full, phase I-IV services enabling drug development companies to bring new medicines to market, has signed a memo of understanding to partner with the International Children’s Advisory Network (iCAN). A worldwide consortium of children’s advisory groups, iCAN is dedicated to giving children and families a voice in health, medicine, research, and innovation by increasing education about the importance of children’s involvement. Synteract is a sponsor at the 2018 iCAN Research Summit in Edinburgh, Scotland, UK, July 8-13, 2018 and will hold two interactive plenary seminar sessions at the event. With chapters across the U.S. and worldwide, iCAN partners with local children’s hospitals and addresses the needs of pediatric clinical research and healthcare and advocates for patients worldwide. In partnering with iCAN, Synteract will expand its access to children and families familiar with clinical research. iCAN will sup
GA-ASI to Fly First Trans-Atlantic Flight of a MALE RPA25.6.2018 16:55 | Pressemelding
On July 10-11, General Atomics Aeronautical Systems, Inc. (GA-ASI) plans to make the first-ever trans-Atlantic flight of a Medium-altitude, Long-endurance (MALE) Remotely Piloted Aircraft (RPA). GA-ASI’s company-owned MQ-9B SkyGuardian RPA is scheduled to fly from the company’s Flight Test and Training Center in Grand Forks, North Dakota, USA, to Royal Air Force (RAF) Fairford in Gloucestershire, UK. The aircraft will then be on static display July 13-15 for the Royal International Air Tattoo (RIAT) airshow being held at RAF Fairford. The flight and display will commemorate the RAF’s centenary celebration (RAF100). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180625005946/en/ GA-ASI’s company-owned MQ-9B SkyGuardian RPA is scheduled to fly from the company’s Flight Test and Training Center in Grand Forks, North Dakota, USA, to Royal Air Force (RAF) Fairford in Gloucestershire, UK. The aircraft will then be on static displa
Quadient Announces General Availability of Quadient Inspire R1225.6.2018 14:30 | Pressemelding
www.quadient.com : Quadient, the award-winning leader in Customer Communications Management (CCM), announced the general availability of its newest release, Quadient Inspire R12, which includes the new Digital Advantage Suite. The updated version of Quadient Inspire is designed to give customers and partners greater control over the systems and processes used to drive consistent communications across all channels with an emphasis on digital experiences. With Inspire R12, users design omni-channel communications in days rather than months with a simple, modern and comprehensive platform. The solution makes it possible to change designs and test for all channels in minutes, with fully integrated tracking and approval processes built in. Additionally, R12 integrates all parts of the communications process from linking journey maps to communications, postal sorting, address, phone and email verifications, email delivery, SMS delivery, mail delivery tracking, and production monitoring to re
The Dementia Discovery Fund Raises $350 Million25.6.2018 13:00 | Pressemelding
The Dementia Discovery Fund (DDF) today announces the completion of its fundraising, with £250 million ($350 million at the time of completion) raised from an influential group of strategic investors committed to developing new medicines for dementia. The goal was met today with a new investment of $60 million from US AARP, the global nonpartisan organisation dedicated to empowering Americans 50 and older to choose how they live as they age. The fundraising far exceeded its initial target of $200 million (£130 million), making it the first and largest venture fund focused entirely on discovering and developing novel therapies for dementia, including Alzheimer’s disease. The DDF makes early stage venture capital investments to develop novel disease-modifying therapeutics for all forms of dementia. The fund is managed by SV Health and was formed through the collaboration of leading pharmaceutical companies (Biogen, Eli Lilly and Company, GSK, Johnson & Johnson, Otsuka (Astex), Pfizer and
Professor Thierry Philip Takes Office as OECI President25.6.2018 12:22 | Pressemelding
Professor Thierry Philip, President of the Institut Curie, has been elected President of the Organisation of European Cancer Institutes ( OECI ) for a three-year term. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180625005600/en/ Pr Thierry Philip (Photo: Business Wire) At the end of June 2018, Professor Philip, an oncologist and pediatrician, will take over as head of this European organization, which brings together 90 institutes and university centers and whose mission is fully devoted to cancer. This European non-governmental, non-profit organization aims to promote cooperation between its members or associate members and pursues a triple objective: to provide cancer patients in Europe with equal access to high-quality care; to assist European institutes with the implementation of a quality system for oncology care; to promote and accelerate the progress of translational research. In this regard, half of the 90 OECI ce